Walleye Trading
EIGR

Walleye Trading’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Walleye Trading’s Portfolio EIGR Stock Details EIGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-17
Closed -$6K – 5466
2018
Q3 		$6K Buy
+17
New +$5.82K ﹤0.01% 5094
2017
Q2 		– Hold
0
– – – 5049
2017
Q1 		– Hold
0
– – – 5267
2016
Q4 		– Hold
0
– – – 5300
2016
Q3 		– Sell
-4
Closed -$2.04K – 5557
2016
Q2 		$2K Hold
4
– – ﹤0.01% 5136
2016
Q1 		$2K Buy
+4
New +$1.99K ﹤0.01% 5134
2015
Q4 		– Sell
-1
Closed -$566 – 5792
2015
Q3 		$1K Buy
+1
New +$530 ﹤0.01% 4850

Other funds holding EIGR

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Walleye Trading's EIGR Position: Q4 2018 in Review

Walleye Trading sold out of Eiger BioPharmaceuticals, Inc. (EIGR) in Q4 2018, closing a stake of 17 shares — an estimated $6K sold.

Walleye Trading first reported a position in EIGR in Q3 2015 and held it in 4 quarters. The position peaked at $6K in Q3 2018. 68 funds tracked by Wall St. Rank hold EIGR as of Q4 2018.

  • Walleye Trading reported no remaining Eiger BioPharmaceuticals, Inc. position as of Q4 2018 after selling out during the quarter.
  • Walleye Trading sold 17 Eiger BioPharmaceuticals, Inc. shares in Q4 2018, an estimated $6K.
  • Walleye Trading first reported a position in Eiger BioPharmaceuticals, Inc. in Q3 2015 and held it in 4 quarters.
  • Walleye Trading's Eiger BioPharmaceuticals, Inc. position peaked at $6K in Q3 2018.
  • 68 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q4 2018.

Based on Walleye Trading's 13F filing for Q4 2018, filed 14 Feb 2019.